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Local antimicrobial, protease and cytokine defense 
systems in psoriatic skin




Background: Psoriasis vulgaris is an infl ammatory skin condition characterized by dramatic 
biochemical and immunological changes. Aims: The aim of the study was to evaluate 
antimicrobial response, tissue degeneration reactions and distribution of infl ammatory cytokines 
in untreated psoriatic skin as well as the correlations between these factors and infl uence 
on the course of the disease. Methods: We evaluated skin samples obtained from routine 
punch biopsies in 40 patients with psoriasis vulgaris. All tissue specimens were examined by 
hematoxylin and eosin staining and immunohistochemistry for human beta defensin 2 (HBD-2), 
matrix metalloproteinase 2 (MMP-2), tumor necrosis factor-alpha (TNF-alpha), interleukin 
6 (IL-6) and IL-8. The staining intensity was semi-quantitatively graded. Results: Numerous 
keratinocytes, fibroblasts and macrophages expressed HBD-2 while the number of 
MMP-2-positive macrophages, fi broblasts and epitheliocytes varied. TNF-alpha-positive 
cells varied from a few to numerous in each microscopic fi eld. IL-6-positive cells varied 
from a few to abundant and IL-8-positive cells from numerous to abundant in each fi eld. 
Limitations: This study had a rather small patient number. Conclusions: Psoriatic skin 
shows a strong correlative increase in skin antimicrobial proteins and enzymes mediating 
tissue degeneration suggesting that the skin maintains compensatory mechanisms during 
persistent remodeling. While individual notable decrease in antimicrobial proteins was 
observed in some tissue samples, generally the increased human beta defensin associated 
with psoriasis is likely to be due to an altered immune status. TNF-alpha, IL-6 and IL-8 are 
common cytokines expressed in psoriatic skin plaques to maintain the infl ammatory cycle. 
HBD-2, MMP-2 and TNF-alpha positively correlate with the severity of psoriasis. Meanwhile, 
the expression of IL-8 signifi cantly decreases with clinically more severe psoriasis, perhaps 
making these factors candidate prognostic factors for psoriatic infl ammation.
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Psoriasis vulgaris is an inflammatory condition of 
the skin with possible nail and joint involvement 
associated with immense biochemical and 
immunological changes. The pathogenesis of psoriasis 
is still unclear but T cells are thought to play a primary 
role. In addition, psoriatic skin classically presents 
with abnormal epidermal changes and modified 
keratinocytes.[1] These abnormal keratinocytes 
produce excess amounts of antimicrobial peptides 
and proteins and induce immune cells to produce 
inflammatory cytokines. One of the antimicrobial 
peptides that has been isolated from psoriatic 
scales is human beta defensin 2 (HBD-2), a cationic 
microbial peptide expressed only by induction with 
pro-inflammatory cytokines such as tumor necrosis 
factor-alpha (TNF-alpha) or interleukin 8 (IL-8). 
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TNF-alpha is highly expressed in psoriatic lesions and 
induces increased HBD-2 expression in keratinocytes. 
HBD-2 is chemoattractive to macrophages and interacts 
with other inflammatory cells.[2,3] Antimicrobial 
peptides play an essential role in permeability 
barrier homeostasis highlighting their function as a 
chemical shield of the skin and a physical barrier. In 
addition to keratinocytes, the natural microflora of 
the skin participate in barrier defense by expressing 
antimicrobial molecules. Upregulation of HBD-2 in 
psoriatic skin is thought to contribute to pathogenesis 
and the resistance to secondary infections caused by 
Gram-negative bacteria or candida. Thus, HBD-2 is a 
dynamic component of the local epidermal defense 
system.[4,5]
Matrix metalloproteinase 2 (MMP-2) is a gelatinase 
that is a zinc-dependent endopeptidase involved in 
the remodeling of extracellular matrix. Gelatinases 
have been found to be important in wound healing, 
angiogenesis, morphogenesis, metastasis and tumor 
invasion. MMP-2 has a unique structure and in its 
active form, can bind to gelatin. MMP-2 and its tissue 
inhibitor are overexpressed in the suprabasal layers of 
psoriatic epidermis.[6]
Interleukin-6 is a multifunctional cytokine produced 
by various cells (fibroblasts, macrophages, monocytes, 
endothelial cells) and participates in host defense, 
immune responses, hematopoiesis and acute and 
chronic inflammatory reactions. It can promote the 
activation of lymphocytes, myeloid cells and epidermal 
keratinocytes resulting in increased inflammation.
Interleukin-8 is secreted by epithelial, endothelial, 
mesothelial and tumor cells, fibroblasts, monocytes 
and neutrophils as an inflammatory response. IL-8 
plays a role in inflammation and wound healing; 
it promotes chemotaxis of all migratory immune 
cells, recruits T cells to the site of inflammation via 
neutrophil activation and has potent angiogenic, 
pro-inflammatory, growth-promoting and matrix 
degradative properties. TNF-alpha strongly induces 
IL-8 production that, with Type I interferons and 
interferon-gamma, is one of the key cytokines in 
psoriatic inflammation.
Tumor necrosis factor-alpha is a pro-inflammatory 
cytokine produced by T cells induced by myeloid 
dermal dendritic cells in psoriatic lesions and 
reciprocally TNF-alpha activates dendritic cells. 
TNF-alpha also has its own anti-inflammatory 
properties; in some patients, anti-TNF therapy can 
induce new onset of psoriasis. Local and systemic 
overexpression of pro-inflammatory cytokines IL-6, 
IL-8 and TNF-alpha are involved in the initiation, 
maintenance, course, severity and recurrence of 
psoriasis.[1,7,8] Therefore, the role of cytokines in the 
pathogenesis of psoriasis has resulted in their frequent 
use in new therapeutic approaches that directly target 
inflammatory events but finding an effective treatment 
is an ongoing challenge.
The aim of the study was to evaluate antimicrobial 
response, tissue degeneration reaction and distribution 
of inflammatory cytokines in untreated psoriatic skin 
as well as the correlations between these factors and 
influence on the course of the disease.
METHODS
Patients
We selected 40 patients with psoriasis between the ages 
of 18 and 70 who had the disease for at least 6 weeks 
and presented with characteristic eruptions at typical 
sites. All patients had a clinically and histologically 
confirmed diagnosis of psoriasis vulgaris. Patients 
who had a severe tan, had previously received local 
and systemic medication or had concomitant diseases 
were excluded. Skin biopsies of new untreated 
psoriatic lesions were obtained using a routine 3 mm 
punch following local anesthesia with lidocaine. Ten 
clinically healthy skin samples obtained during nevus 
excision procedure were used as control material.
The study was approved by the ethical committee at 
Riga Stradins University, permit issued on September 
10, 2009.
Methods
Skin biopsy tissue was fixed in Stefanini’s solution, 
dehydrated and embedded in paraffin.[9] Four 
micrometer thick sections were prepared and stained 
with hematoxylin and eosin.[10]
Immunohistochemistry (IHC)
Human beta defensin 2 (Cat No AF2758, Lot No VJU01, 
obtained from goat, 1:100 dilution, R&D Systems, 
Germany), MMP-2 (Cat No AF902, Lot No DUB03, 
obtained from goat, 1:100 dilution, R&D Systems, 
Germany), TNF-alpha (code ab 6671, obtained from 
rabbit, 1:100 dilution, Abcam, Cambridge, UK), 
IL-6 (NYRhIL6: Sc-73319, obtained from mouse, 
1:50 dilution, Santa Cruz Biotechnology, Inc., USA) and 
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IL-8 (C-19: Sc-1269, obtained from goat, 1:50 dilution, 
Santa Cruz Biotechnology, Inc., USA) primary 
antibodies were used in a standard biotin–streptavidin 
immunohistochemistry process.[11] Skin biopsy tissues 
were deparaffinized, washed in alcohol and water, 
washed for 10 min in wash buffer (tris-buffered 
saline) and microwaved in boiling EDTA buffer for 
5 min. The samples were allowed to cool and washed 
twice in wash buffer for 5 min. Samples were blocked 
with normal blocking sera for 20 min to decrease 
background staining. All samples were stained with 
primary antibodies for 1 h, washed for 10 min in wash 
buffer and then stained for 30 min with Dako REALTM 
Detection System (LSABTM+) with biotin-related 
secondary antibodies (code K1015, DakoCytomation, 
Denmark) and washed again for 5 min in wash buffer. 
We further stained our samples for 25 min with 
LSABTM + with peroxidase-labeled streptavidin (code 
K0690, DakoCytomation, Denmark), washed for 
5 min in wash buffer and processed for 10 min with 
DAB substrate-chromogen system (code K3468, 
DakoCytomation, Denmark) to stain positive structures 
brown. Samples were then rinsed in running water 
and counterstained with hematoxylin.
Samples were examined on a Leica DC 300F camera 
and image processing and analysis was performed on 
Image Pro Plus 6.0 software (Media Cybernetics, Silver 
Spring, Maryland, USA).
The intensity of immunostaining was 
semiquantitatively graded, as follows:[12]
• A few positive structures in the visual field at 
magnification of  ×400 were labeled +
• A moderate number of positive structures in 
the visual field at magnification of ×400 was 
labeled ++
• Numerous positive structures in the visual field 
at magnification of ×400 were labeled +++
• An abundance of positive structures in the 
visual field at magnification of ×400 was 
marked ++++.
For statistical analyses, we used non-parametric 
statistics and Spearman’s rank correlation coefficient.[13]
RESULTS
The psoriatic epidermis of our tissue samples was 
characterized by loss of the granular cell layer, 
parakeratosis, orthokeratosis and acanthosis as 
well as the formation of the characteristic Munro 
microabscesses. We observed increased mitotic 
activity in basal cells. Polymorphonuclear leukocytes 
and lymphocytes infiltrated dermis and epidermis. 
The arterioles within the papillary dermis were 
slightly dilated and showed sclerotic changes.
Numerous (+++) to abundant (++++) keratinocytes, 
fibroblasts and macrophages expressed HBD-2 with 
more pronounced expression in sites of well-defined 
inflammation [Figure 1 and Table 1].
The number of MMP-2 positive macrophages, 
fibroblasts and keratinocytes varied from a few (+) to 
abundant (++++), mainly in the dermis of psoriatic 
skin [Figure 2].
We found TNF-alpha-positive lymphocytes and 
macrophages in almost all skin samples, particularly in 
the papillary dermis, walls of blood vessels and eccrine 
sweat glands. The number of TNF-alpha-positive cells 
varied from a few (+) to numerous (+++) in each 
visual field [Figure 3].
We detected IL-6-positive cells ranging from a few (+) 
to abundant (++++) in each visual field [Figure 4], 
while IL-8-positive cells were numerous (+++) to 
abundant (++++) in each visual field. We detected IL-8 
in the epidermis and dermis, inflammatory infiltrates, 
hair follicles and surrounding blood vessels [Figure 5].
Healthy skin samples obtained during nevus 
excision procedure as negative controls are shown 
in Figures 6-10.
Figure 1: Abundance of human beta defensin 2-containing 
keratinocytes and connective tissue cells in psoriatic skin lesion 
(HBD-2 IHC, ×200)
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We found a strong positive correlation between 
HBD-2 and MMP-2 expression (Spearman’s rank 
correlation coefficient was 0.886 [P < 0.001]), a 
moderate positive correlation between TNF-alpha and 
MMP-2 (Spearman’s rank correlation coefficient was 
0.795 [P < 0.001]) and a moderate positive correlation 
between IL-6 and IL-8 (Spearman’s rank correlation 
coefficient 0.594 [P < 0.001]). The correlations 
Table 1: Relative amount of HBD-2, MMP-2, TNF-alpha, IL-6 and IL-8 positive structures in infl ammatory psoriatic lesions
Patient number Age Sex Duration of disease HBD-2 MMP-2 TNF-alpha IL-6 IL-8
1 18 Male 7 months + +++ ++ ++ +++
2 18 Male 16 years ++ ++++ +++ + +
3 19 Female 6 months + ++ +++ + +++
4 19 Male 6 years + ++ ++ ++ +++
5 19 Male 10 years ++++ ++++ ++ ++ +
6 25 Male 3 months + ++ ++ 0 0
7 27 Female 6 months ++ + + + +
8 28 Male 14 years ++ ++ ++ ++ ++
9 29 Male 2 weeks ++ + + + ++
10 30 Male 1 year +++ + + 0 ++++
11 30 Male 6 months + + ++ ++ ++++
12 34 Female 5 years +++ ++ +++ ++ ++++
13 36 Female 1 year ++++ ++++ + + +
14 36 Male 4 years ++++ ++++ ++++ ++++ +++
15 36 Male 20 years ++++ ++++ + + 0
16 37 Male 2 years ++++ ++++ + + ++
17 37 Male 2 years ++ +++ ++ ++ +++
18 38 Male 7 months ++++ ++++ ++++ ++ ++
19 40 Female 1 year +++ +++ +++ +++ ++++
20 40 Male 1 year ++++ ++++ +++ 0 +
21 43 Male 6 months ++ ++ + ++ ++++
22 43 Male 18 years ++++ ++++ + + +
23 43 Male 40 years ++++ ++++ ++++ +++ +++
24 44 Male 15 years +++ ++ +++ +++ ++++
25 45 Male 1 month ++++ + ++ ++++ +
26 45 Female 1 year ++ 0 0 + +
27 45 Female 20 years ++ + 0 0 +
28 47 Male 6 months +++ +++ +++ +++ +++
29 48 Female 10 years ++++ ++++ ++ ++ ++
30 50 Male 20 years ++++ ++++ +++ + 0
31 51 Male 28 years ++++ ++++ ++++ +++ ++
32 53 Male 5 years + 0 0 ++++ +
33 64 Female 40 years ++++ ++++ ++ 0 0
34 65 Male 6 months ++ ++ + +++ ++
35 65 Male 1 year + ++ +++ ++ +++
36 66 Male 40 years + + 0 ++ ++
37 67 Male 1.5 years + + 0 ++ +
38 68 Male 44 years ++++ ++++ ++ ++++ ++++
39 69 Male 3 years ++++ ++++ ++++ + +
40 70 Male 5 years + ++++ ++ ++ ++++
Mean +++ +++ ++ ++ ++
Spearman’s rank correlation coeffi cient 0.7104
0.5687
0.5000
HBD-2: Human beta defensin 2, MMP-2: Matrix metalloproteinase 2, TNF-alpha: Tumor necrosis factor-alpha, IL-6: Interleukin 6, IL-8: Interleukin 8, +: Few positive 
structures in the visual fi eld, ++: A moderate number of positive structures in the visual fi eld, +++: Numerous positive structures in the visual fi eld, ++++: An abundance 
of positive structures in the visual fi eld
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Figure 2: Numerous MMP-2-expressing cells in the epidermis 
and papillary dermis of psoriatic patient skin (MMP-2 IHC, ×200)
Figure 3: Numerous TNF-alpha positive inflammatory cells, 
particularly in psoriasis, populated the papillary dermis (TNF-
alpha IHC, ×250)
Figure 4: Numerous IL-6 positive cells throughout the epidermal 
and dermal layers of psoriatic skin (IL-6 IHC, ×100)
Figure 5: Marked expression of IL-8 in the epidermis and dermal 
infl ammatory cells (IL-8 IHC, ×200)
Figure 6: Basal keratinocytes and sparse connective tissue cells 
containing human beta defensin 2 in healthy skin (HBD-2 IHC, 
×400)
Figure 7: A few to a moderate number of MMP-2-expressing cells 
in the epidermis and papillary dermis of healthy skin (MMP-2 
IHC, ×400)
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between HBD-2 and TNF-alpha, TNF-alpha and IL-6 
and TNF-alpha and IL-8 were weak. In contrast, we 
did not detect a correlation between HBD-2 and IL-6, 
HBD-2 and IL-8, MMP-2 and IL-6 or MMP-2 and IL-8.
We found statistically significant correlations between 
the following factors and disease severity:
• Moderate positive correlation between 
HBD-2 and disease severity; Spearman’s rank 
correlation coefficient was 0.484 (P value 
0.002)
• Weak positive correlation between MMP-2 and 
disease severity; Spearman’s rank correlation 
coefficient was 0.318 (P value 0.046)
• Weak positive correlation between TNF-alpha 
and disease severity; Spearman’s rank 
correlation coefficient was 0.363 (P value 0.021)
• Moderate negative correlation between IL-8 and 
disease severity; Spearman’s rank correlation 
coefficient was 0.515 (P value 0.001).
No statistically significant correlations were found 
with gender or age of the psoriasis patient.
DISCUSSION
Various types of human cells, including epithelial 
cells, express antimicrobial peptides. The peptides 
act on a broad spectrum of bacteria, fungi and 
viruses. They can disrupt or penetrate the bacterial 
membrane and interfere with intracellular functions. 
Human beta defensins link cell surface receptors to 
facilitate chemotaxis and in particular, HBD-2 can 
recruit immature dendritic cells and T cells to sites of 
interest. HBD-2 was previously shown to be produced 
by human epithelial cells in psoriatic skin.[14,15] It is 
expressed at low levels in healthy keratinocytes and 
is often upregulated during inflammation or infection, 
suggesting that the HBD-2 increase is a secondary 
response if the primary defense against inflammation 
is not sufficient.[16] Previous studies have found a 
substantial relationship between an increase in human 
beta defensin genomic copy number and the risk of 
psoriasis onset.[17,18] In our study, we evaluated HBD-2 
expression in untreated psoriatic lesions and found 
that it was expressed in all samples. Furthermore, it 
was most highly expressed in inflammatory areas, 
consistent with the model of participation of the innate 
immune system in psoriasis. Some biopsies showed a 
significant decrease in HBD-2 expression. This finding 
may be related to the severity or length of the disease as 
fewer HBD-2 positive cells were found more commonly 
in patients with a history of psoriasis for only a few 
months. Patients with a longer course of psoriasis 
Figure 8: Separate TNF-alpha positive basal keratinocytes in 
healthy skin tissue (TNF-alpha IHC, ×400)
Figure 9: A few IL-6 positive cells in epidermis of healthy skin 
(IL-6 IHC, ×400)
Figure 10: A few to a moderate number of IL-8-containing 
keratinocytes and dermal connective tissue cells in healthy skin 
(IL-8 IHC, ×400)
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and more pronounced inflammation (both clinically 
and histologically) in their skin biopsy samples 
presented more obvious HBD-2 expression. Various 
studies have looked at serum levels of antimicrobial 
peptides as a possible marker of psoriasis severity 
or disease activity. Recent data suggest that HBD-2 
serum levels in untreated patients may not relate to 
the severity of psoriasis but, their levels significantly 
increase after fumaric acid ester therapy. Additionally, 
treatment with the adipokine, visfatin can increase 
HBD-2 suggesting that psoriasis is related to metabolic 
syndromes.[19,20] A decrease in HBD-2 serum levels 
has been detected after topical calcipotriol and 
betamethasone dipropionate combination therapy.[21] 
These data suggest that HBD-2 levels could be used as 
a possible marker for therapeutic efficacy.
Matrix metalloproteinases in serum and synovial fluid 
have become valuable biomarkers for the evaluation of 
psoriatic arthritis and its treatment with TNF inhibitors, 
which are also used in psoriasis.[22,23] There are also 
available data that suggest that MMPs are important 
biomarkers of psoriasis activity and therapeutic 
response.[24-27] Previous studies have found that 
ultraviolet radiation and vitamin D levels contribute to 
the severity, course and treatment success of psoriasis. It 
has been shown that serum vitamin D levels positively 
correlated with HBD-2 expression levels. In addition, 
a positive correlation exists between ultraviolet 
radiation and the expression of gelatinase MMP-2.[28,29] 
We found a clear upregulation of MMP-2 expression 
in our samples; these data support the possibility that 
it could be utilized as a marker for psoriasis activity 
or a therapeutic target.[30] We found a strong positive 
correlation between MMP-2 and HBD-2 and both of 
them could be used as diagnostic/prognostic markers 
for psoriasis. In some of the psoriasis patients observed 
in this study, HBD-2 expression was low even though 
we could still find numerous MMP-2-positive cells. 
One potential explanation is that recent ultraviolet 
irradiation resulted in MMP upregulation. While 
antimicrobial peptide levels would be altered in such 
a situation, we excluded recently tanned patients 
from our study. Furthermore, we did not measure 
vitamin D levels in our patients and vitamin D could 
also be a possible key factor in HBD-2 and MMP-2 
expression. We were unable to find any previous 
reports that simultaneously compared HBD-2 and 
MMP-2 in untreated psoriatic skin. Interestingly, the 
excessive expression of MMP-2 and almost absent 
HBD-2 expression has been found in biopsies of 
hidradenitis suppurativa, possibly due to MMP-2 
providing a proteolytic environment and inactivating 
HBD-2.[31] MMP-2 also positively correlates with 
TNF-alpha, supporting the model that MMP-2 plays an 
important role in the pathogenesis of psoriasis.
The pro-inflammatory cytokines TNF-alpha, IL-6 
and IL-8 are highly expressed in psoriasis and form 
a complex that induces the inflammatory signaling 
cascade resulting in the classic psoriatic plaque. 
Innate immune cells produce the key cytokines 
TNF-alpha and IL-6 which in turn activate myeloid 
dendritic cells which present antigens to produce new 
inflammatory mediators. Thus, T cells differentiate, 
keratinocytes are activated and antimicrobial peptide 
(HBD-2) and pro-inflammatory cytokines (TNF-alpha 
and IL6) are produced. IL-8 is a known cytokine with 
pro-inflammatory and growth-promoting activities and 
also induces keratinocyte proliferation.[1,32,33] HBD-2 can 
also induce cytokine production, such as TNF-alpha 
and IL-6.[34,35] We detected variable, predominantly 
moderate expression of TNF-alpha, IL-6 and IL-8 in our 
skin samples with more prominent upregulation in the 
skin from patients with a long history of the disease. 
IL-6 and IL-8 showed a relevant positive correlation 
which is consistent with the current understanding of 
psoriasis pathogenesis. It appears that persistent skin 
inflammation is characterized by pro-inflammatory 
cytokine expression. Thus, these factors may become 
promising prognostic tools of the disease course.
Our data confirm that inflammatory cytokines are 
primary players in the pathogenesis of psoriasis but 
the antimicrobial peptide HBD-2 and gelatinase 
MMP-2 are also important factors and could be further 
considered in therapeutic approaches to psoriasis.
As a limitation, it should be noted that the study had a 
rather small patient number.
CONCLUSIONS
TNF-alpha, IL-6 and IL-8 are common cytokines 
expressed in psoriatic skin plaques to maintain the 
inflammatory cycle.
Antimicrobial peptide HBD-2, tissue degeneration 
marker MMP-2 and TNF-alpha positively correlate 
with the severity of psoriasis. On the other hand, 
the expression of IL-8 significantly decreases with 
clinically more severe psoriasis. Perhaps, HBD-2, 
MMP-2, TNF-alpha and IL-8 therefore can be considered 
as prognostic factors for psoriatic inflammation.
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